Teva makes a drug which is very valuable for those who need it. If it's over-prescribed, speak to the doctors. As for Teva's abandoning branded products, the wisdom of that is a whole other subject; hopefully Teva will realize that in today's market to rely solely on generics is to abandon a much more profitable revenue stream, as copaxone demonstrated.
Hello user Logout | profile
You have watched of 10 articles
U.S. Senate votes overwhelmingly for tougher North Korea sanctions (Reuters)